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cycle with terminal differentiation. 
A unipotent host cell population 
acts as stem cells, which proliferate 
and migrate from the center of 
each lobule to the periphery, cease 
division, and die through apoptosis. 
During this journey they carry 
along their symbionts, which divide 
in the center, stop dividing, and 
subsequently become digested in 
the periphery. Digestion thus serves 
both in host nourishment and the 
control of the symbiont population 
density. 
What do we know about the 
symbionts? The Endoriftia 16S 
rRNA phylotype was detected in 
the environment, both on surfaces 
and in the water. Its metagenome 
shows the presence of genes for 
the oxidative TCA cycle indicating 
the ability to live as heterotrophs 
outside the host. Genes for 
chemotaxis suggest that Endoriftia 
actively seeks the prospective host. 
This points to a highly versatile 
bacterium capable of surviving in 
the biofilms of hydrothermal vents 
and adjacent deep sea as well 
as thriving under host control as 
endosymbionts.
How do vent and seep tubeworms 
differ? Some tubeworms, such as 
Riftia, inhabit hydrothermal vents, 
while other species live on whale 
bones or at seeps, deposits of oil 
and gas leaking through sediments 
to the sea floor. Vents are highly 
disturbed, short-lived ecosystems, 
while seeps may persist for ten 
thousands of years. Consistent 
with the temporal dynamics of 
these contrasting ecosystems, 
Riftia grows fast and is short-
lived, whereas Lamellibrachia 
luymesi from the seeps of the 
Gulf of Mexico grows slowly and 
is — with estimated ages of up to 
300 years — among the longest 
lived of any of the non-colonial 
invertebrates. Although carbon 
fixation rates of Riftia exceed those 
of Lamellibrachia, both symbionts 
are highly active and support 
similar, high cell proliferation rates. 
However, apoptosis rates are low in 
Riftia, but in Lamellibrachia match 
those of proliferation. Thus Riftia 
grows fast, whereas Lamellibrachia 
grows slowly and consistently 
renews its tissue, supporting 
longevity. 
Who are the tubeworms’ relatives? 
Vestimentiferan tubeworms belong 
to the small polychaete family 
Siboglinidae (Figure 1). Unlike other 
polychaetes, siboglinids share 
an obligate symbiotic life style in 
chemosynthesis-based ecosystems, 
such as vents, seeps, and whale 
bones. The thiotrophic symbiosis 
probably evolved once rather than 
several times independently. This 
is supported by the position of the 
trophosomes at the exact same 
location in the first segment of the 
different worms. The remarkable 
differences of trophosome origins, 
however, suggest that the last 
common ancestor harbored 
symbionts in several tissues. 
Consequently, in frenulates, the 
trophosome became restricted to 
the gut, in Osedax to the somatic 
mesoderm, and in vestimentiferans 
and its sister Sclerolinum to the 
visceral mesoderm. Horizontal 
transmission not only ensures 
continuation of symbiosis, it also 
allows for the uptake of appropriate 
symbionts, which can be selected 
in each generation anew. Most 
remarkably, Osedax, which colonizes 
whale bones, must have replaced 
its thiotrophic symbiont with 
heterotrophic Oceanospirillales 
nourished by the host.
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What is Polo and what are Plks? Plk 
stands for Polo-like kinase. In the 
1980s, genetic screens in budding 
yeast and Drosophila identified 
several key regulators of mitosis, 
including the founding member of 
the Polo kinase family. Since then, a 
total of five mammalian paralogs of 
the Drosophila Polo gene have been 
discovered. These exhibit largely non-
redundant functions and are differently 
expressed, localized, and regulated. 
The Polo homolog Plk1 is common to 
all eukaryotes, apart from plants and 
certain protozoan parasites. Plk4 is 
also present in most vertebrates and 
invertebrates and probably arose early 
on, in a first round of gene duplication. 
The evolutionarily ‘younger’ Plk2 sub-
family is only found in some bilaterian 
animals and comprises two genuine 
kinases, Plk2 and Plk3, as well as the 
kinase-deficient Plk5. 
Is Plk1 the leader of the pack? 
Plk1 is a wizard of both mitosis and 
meiosis (M phase of the cell cycle). It 
is expressed in proliferating cells and 
regulates many aspects of M-phase 
progression — notably mitotic entry, 
spindle architecture and positioning, 
sister-chromatid separation, and 
cytokinesis. Hence, inactivation of 
Plk1 in cultured cells leads to cell-
cycle arrest in early mitosis, followed 
by apoptosis. In addition, Plk1 is 
also involved in key processes, such 
as release of amphibian eggs from 
cell-cycle arrest upon fertilization, 
recovery of mammalian cells from 
DNA damage, and RNA polymerase 
III-dependent transcription. At this 
point in time, it seems fair to state 
that Plk1 is top dog of the family. But 
Plk4, another key regulator of cell 
division (see below), is increasingly 
challenging Plk1’s leadership position. 
In contrast, the roles of the younger 
Plk2 family members still remain 
sketchy.
How does Plk1 manage all these 
different functions? The answer lies 
in the structure. Plk1, like all other 
family members, has a topology with 
two conserved domains: an amino-
terminal serine/threonine kinase 
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Figure 1. Immunofluorescence analysis of human hTERT-RPE1 cells showing Plk1 (green, left panel) at kinetochores as well as spindle poles 
and Plk4 (green, right panel) at centrosomes. Microtubules are shown in red, DNA in blue. Scale bars represent 5 μm. (Image: C. von Schubert; 
A.I. Ferrand, IMCF Biozentrum.) domain and a carboxy-terminal 
substrate-binding domain, known as 
the polo-box domain (PBD). Plk1 is a 
very busy kinase and several recent 
phospho-proteomics studies indicate 
that it targets a large number of 
physiological substrates. To perform 
its various tasks, Plk1 is targeted to 
distinct subcellular sites, such as 
centrosomes during G2 phase and 
kinetochores, spindle poles and the 
spindle midzone/midbody during M 
phase (Figure 1). Plk1 localization 
is governed by docking of the 
PBD to specific motifs (Ser–Ser/
Thr–Pro) that have been primed 
by phosphorylation. This beautiful 
mechanism confers both temporal 
and spatial control over Plk1 activity. 
For example, Plk1 docking to early 
mitotic interaction partners is often 
primed by cyclin-dependent kinase 
1 (Cdk1). Concomitantly, this same 
kinase prevents Plk1 from binding 
to late mitotic interaction partners 
through inhibitory phosphorylation 
adjacent to PBD-binding motifs. 
When Cdk1 activity is reduced 
at the onset of mitotic exit, this 
suppression is relieved and Plk1 
primes its own recruitment to proteins 
that are important for the initiation 
of cytokinesis. The spectrum of 
Plk1 regulation also includes more 
conventional mechanisms, notably 
activation-loop phosphorylation by 
Aurora kinases and proteasomal 
degradation at the hands of the 
major mitotic ubiquitin ligase known 
as anaphase-promoting complex/
cyclosome (APC/C). I’ve heard that Plk4 is a master 
regulator of centriole and basal 
body formation — is this true? Yes, 
Plk4 indeed plays a key role in the 
biogenesis of centrioles and basal 
bodies. Centrioles are important for 
the assembly of centrosomes — the 
major microtubule-organizing centers 
of animal cells (Figure 1) — and 
as basal bodies they trigger the 
formation of cilia and flagella. 
Depletion of Plk4 results in loss of 
centrioles, whereas its overexpression 
triggers excessive centriole formation. 
Murine Plk4–/– embryos die early 
in development, confirming that 
Plk4-deficient cells are defective in 
cell-cycle progression. In most cells, 
Plk4 levels are extremely low and this 
reflects a self-destruction mechanism 
based on trans-autophosphorylation 
within Plk4 dimers, followed by 
ubiquitylation and proteasomal 
degradation. How Plk4 regulates 
centriole duplication remains to be 
understood, but clearly the PBD is 
important for Plk4 localization to 
centrosomes. Interestingly, Plk1 also 
plays an important role in centrosome 
biology in that it contributes to restrict 
centriole duplication to once per cell 
cycle.
Are Plk2 and Plk3 merely 
afterthoughts of vertebrate 
evolution? That’s a bit harsh! 
Perhaps it will simply take more time 
to better understand what these 
kinases are actually doing — but, 
obviously, they are not required in 
many species. Both Plk2 and Plk3 were originally identified as early-
response genes that are upregulated 
following serum stimulation of 
quiescent murine fibroblasts. 
Subsequently, both genes were also 
assigned tumor-suppressor roles: 
Plk2 expression was reported to 
be downregulated in several types 
of cancer, whereas Plk3–/– mice 
are prone to tumor development. 
Remarkably, however, Plk2 as well 
as Plk5 are also expressed in non-
proliferative tissue of the central 
nervous system and Plk2 was 
implicated in synaptic plasticity. 
Hence, although Plk2 family members 
may not be essential for life, they are 
likely to play important roles. This 
rings a cautionary bell with regard to 
the development of Plk1 inhibitors as 
anti-cancer drugs (see below).
What about Plk5, the new kid on 
the block? Plk5 probably functions 
as a decoy kinase. In humans, for 
example, the Plk5 sequence contains 
a stop codon within the kinase 
domain, and a protein fragment 
is only resurrected thanks to a 
start codon downstream, resulting 
in expression of a catalytically 
inactive, truncated protein. Although 
expressed, Plk5 was initially given 
the cold shoulder because it shows 
the characteristics of a pseudo-
gene. However, recent studies have 
now shown that Plk5 is expressed in 
non-proliferative tissues, mostly the 
brain. In addition, it was found to be 
upregulated in fibroblasts upon serum 





Most small children can tell you that 
‘reptiles’ are the snakes, lizards, 
crocodiles, and turtles (perhaps with 
the dinosaurs thrown in) — suggesting 
that it’s easy to tell the difference 
between reptiles and other animals. 
Unfortunately, evolutionary biologists 
struggle with the same task, because 
phylogenetic analysis tells us loud 
and clear that these different types of 
what we loosely call ‘reptiles’ are not 
particularly closely related to each 
other (Figure 1). On the evolutionary 
tree, some of them (dinosaurs, 
crocodiles) are much more closely 
related to birds than to the other 
animals that we call reptiles. Other 
reptiles are the descendants of 
very ancient lineages; for example, 
turtles separated from the other 
reptiles, including the now-dominant 
Squamata (lizards and snakes), at 
least 200 million years ago. And 
another 200-million-year-old lineage 
has left just a single survivor, a lizard-
like creature (the tuatara), on a few 
islands in New Zealand.
So, why do we still talk about 
‘reptiles’, when an analysis based on 
shared derived traits (cladistics) says 
that the Reptilia are not a ‘natural’ 
(monophyletic) evolutionary group 
for which a single common ancestor 
can be defined that excludes all non-
reptiles such as birds? The reason is 
that a comparison based on external 
morphology (phenetics) would yield 
the opposite conclusion: for example, 
crocodiles and tuataras really do 
look a lot like lizards. For example, 
they share a distinctive body shape, 
and are covered in scales. It is this 
outer resemblance which led to the 
concept of the Reptilia, and which 
has kept it alive and kicking even 
though the creatures known as 
reptiles are only distantly related 
to each other. So, the problem with 
defining the Reptilia actually throws 
up an interesting biological puzzle: 
given their divergent ancestries, 
why do these animals all look so 
much alike? The answer involves a 
fundamental feature of reptiles: the 
way in which they control their body 
temperature.
Primer Taking the heatBy and large (with more than 8,000 
species, there are exceptions to almost 
every rule), reptiles are ectotherms. 
That is, they rely upon ambient 
thermal heterogeneity to regulate 
their internal temperatures — for 
example, by basking in sunlight to 
become warm, and moving to shade 
to cool down. This tactic is in striking 
contrast to endotherms, such as 
birds and mammals, which rely upon 
metabolic heat production to maintain 
a high and relatively constant internal 
temperature. Endotherms are like 
racing cars — they keep their engines 
revving at high speed most or all of the 
time and so can perform at high speed. 
For example, they not only can move 
quickly, but they can also maintain 
that speed because their hearts and 
lungs can deliver extra oxygen to 
the muscles that are doing the hard 
work. And because they generate their 
own heat, endotherms can function 
effectively even in cold conditions.
At first sight, this looks like a clear 
case of an evolutionary advance: 
the primitive cold-blooded low-
performing reptiles have been 
replaced by sophisticated high-
performing mammals and birds. But 
that interpretation is wrong: first, 
ectotherms have not been replaced 
by endotherms, and when you include 
fish there are a lot more species 
of ectothermic vertebrates than 
endothermic vertebrates. Indeed, some 
authorities believe that crocodilians 
evolved from endothermic ancestors — 
something we wouldn’t expect to 
happen if endothermy was ‘better’. 
Second, ectotherms are not ‘cold-
blooded’ — a desert lizard may run 
around with a higher body temperature 
than the rodent who lives in the 
adjacent burrow. The fundamental 
difference between endotherms and 
ectotherms is in the source of the heat 
used to regulate body temperature: 
endotherms make their own, whereas 
ectotherms exploit environmental heat. 
Because ectotherms do not need to 
create their own heat, their metabolic 
rates are about one-tenth of those of 
a similar-sized endotherm, massively 
reducing energy needs. They can’t fuel 
sustained muscular activity by aerobic 
means, but they have a fallback, as 
anaerobic metabolism usually can 
keep them going long enough to find 
the food item or shelter that they 
require. If endotherms are racing cars, 
ectotherms are pushbikes, less capable overexpression triggered a G0/G1-like 
arrest. Thus, it has been proposed 
that Plk5 function is related to stress 
responses. 
Are Plks attractive drug targets for 
cancer treatment? Yes and no — the 
future will tell. So far, the focus has 
been on targeting Plk1: human Plk1 
is highly expressed in proliferating 
tissues, often upregulated in tumors, 
and elevated expression in tumors 
is associated with poor prognosis. 
Furthermore, overexpression of Plk1 
leads to transformation of cultured 
cells, likely via the stimulation of 
a mitotic transcription program 
involving the transcription factor 
FOXM1. In addition, it is in principle 
possible to interfere with Plk1 
function not only via the usual route 
of ATP-competitive inhibitors (which 
of course raises concerns about 
specificity), but also by interfering 
with PBD binding to docking 
proteins. Several early cell-culture 
studies had suggested that tumor 
cells may be more sensitive to Plk1 
inhibition than normal cells, but 
whether a sufficient therapeutic 
window can be found in a clinically 
relevant context remains to be 
determined. Several Plk1 inhibitors 
are presently in clinical trials and 
it will be interesting to see how 
these agents fare for the benefit of 
patients.
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